40 participants
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2011-09-19
- Start Date:
- 2007-01-31
- Completion:
- 2010-01-31
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet